CoChat

Effects of BDNF and NT‐4/5 on Striatonigral Neuropeptides or Nigral GABA Neurons In Vivo

Arenas, Ernest, Åkerud, Peter, Wong, Vivien, Boylan, Carolyn, Person, Håkan, Lindsay, Ronald M., Altar, C. Anthony · 1996 · European Journal of Neuroscience
Cited by 67

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Supranigral infusions of the TrkB‐receptor‐preferring neurotrophins BDNF or NT‐4/5 augment locomotor behaviours, pars compacta firing rates and striatal dopamine metabolism. However these actions of BDNF or NT‐4/5 may involve other neurotransmitter systems in addition to dopamine neurons in the substantia nigra. We thus investigated the effects of 2‐week supranigral infusions of BDNF or NT‐4/5 on rat peptidergic striatonigral neurons and nigral GABAergic neurons. Radioimmunoassay revealed that BDNF and NT‐4/5 elevated substantia nigra levels of substance P (by 46 and 57% respectively) and substance K (by 64 and 81%). In addition, BDNF elevated substance K by 59% in a nigral projection area, the superior colliculus. NT‐4/5 elevated dynorphin A in the substantia nigra (by 52%) and met‐enkephalin in substantia nigra and globus pallidus (by 89%). None of these neuropeptides were altered in the striatum. Consistent with these findings, supranigral infusions of BDNF elevated the mRNA for preprotachykinin A in striatal neurons. In the same animals, glutamic acid decarboxylase (GAD)67 mRNA was increased by 48% in the substantia nigra. The cross‐sectional area of GAD 67‐positive neuronal somata in the BDNF‐infused nigra was increased by 59%, and 70% of nigral GABAergic neurons had a cross‐sectional area >550 μm 2, whereas 95% of the neurons in vehicle‐infused animals had cross‐sectional areas <550 μm 2. Thus, supranigral infusions of BDNF or NT‐4/5 increase tachykinin mRNA and protein levels within striatonigral neurons and increase the size and GAD 67 mRNA expression levels of nigral GABAergic neurons. These results suggest that BDNF or NT‐4/5 may modify the output of the basal ganglia not only through effects on dopamine neurons but also by increasing neurotransmission in striatonigral peptidergic and nigral GABAergic pathways.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/j.1460-9568.1996.tb01314.x

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 67

Metadata

Authors
Arenas, E., Åkerud, P., Wong, V., Boylan, C., Person, H., Lindsay, R. M., & Altar, C. A.
Venue
European Journal of Neuroscience
Publisher
Wiley
Published
1996-08
Volume
8
Issue
8
Pages
1707-1717
ISSN
  • 0953-816X (ISSN-L)
  • 1460-9568
OpenAlex
W2065766179
Cited by
67
References
4
FWCI
2.15
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Effects of BDNF and NT‐4/5 on Striatonigral Neuropeptides or Nigral GABA Neurons In Vivo. https://app.cochat.ai/papers/10.1111/j.1460-9568.1996.tb01314.x
The paper
Arenas, E., Åkerud, P., Wong, V., Boylan, C., Person, H., Lindsay, R. M., & Altar, C. A. (1996). Effects of BDNF and NT‐4/5 on Striatonigral Neuropeptides or Nigral GABA Neurons In Vivo. European Journal of Neuroscience. https://doi.org/10.1111/j.1460-9568.1996.tb01314.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.